Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Fennobon launches cholesterol-lowering chewing gum with Reducol

Sep. 10, 2007

Biopure and FDA discuss compassionate use protocol for Hemopure

Sep. 7, 2007

Mircera reaches first market for CKD-associated anemia

Sep. 7, 2007

PhytoMedical reports preliminary results of preclinical diabetes trial

Sep. 7, 2007

Isis begins phase I trial of ISIS-325568 for type 2 diabetes

Sep. 6, 2007

Phoqus begins phase II trial of Chronocort for CAH

Sep. 6, 2007

Jerini regains North American marketing rights to icatibant in hereditary angioedema

Sep. 5, 2007

Recent patents claim novel agents for obesity and metabolic disorders

Sep. 5, 2007

Recent patents disclose novel antidiabetic agents

Sep. 5, 2007

Studies show improved lipids, no blood pressure increase with MK-0859

Sep. 4, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...